AEGR
Aegerion Pharmaceuticals
AEGR
AEGR
Delisted
AEGR was delisted on the 29th of November, 2016.
95 hedge funds and large institutions have $721M invested in Aegerion Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 41 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
64% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 53
Holders
95
Holding in Top 10
2
Calls
$23.1M
Puts
$46M
Top Buyers
| 1 | +$32.3M | |
| 2 | +$27.8M | |
| 3 | +$23M | |
| 4 |
Goldman Sachs
New York
|
+$12.3M |
| 5 |
SCM
Scopia Capital Management
New York
|
+$6.83M |
Top Sellers
| 1 | -$29.2M | |
| 2 | -$29.2M | |
| 3 | -$22.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.8M |
| 5 |
HM
HealthCor Management
New York
|
-$15.5M |